Recombinant
RabMAb

Anti-CTLA4 antibody [EPR1476] (ab134090)

Publishing research using ab134090? Please let us know so that we can cite the reference in this datasheet.

ab134090 has been referenced in 3 publications.

  • Zhou J  et al. Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma. Exp Ther Med 15:4979-4986 (2018). PubMed: 29805521
  • Giles AJ  et al. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer 6:51 (2018). WB ; Human . PubMed: 29891009
  • Lee EH  et al. Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice. Oncotarget 7:14983-5017 (2016). PubMed: 26934552

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up